- Fee assured
- Verified this account
I am a Consultant Gynaecologist at Oxford University Hospitals NHS Foundation Trust and the Clinical Lead for Colposcopy.
I received my medical degree from the Humboldt-University of Berlin, Germany, and split my specialist training in Obstetrics & Gynaecology between Berlin and Oxford. I spent a further 4 years as a postdoctoral research fellow at Harvard Medical School / Brigham & Women's Hospital in Boston (USA) where I have been working on the molecular mechanisms of human papillomavirus (HPV) associated carcinogenesis and drug discovery strategies for cervical cancer.
I joined the University of Oxford in 2011 as a Clinical Lecturer and was appointed as Senior Fellow in Women's Health at the Nuffield Department of Reproductive & Women's Health in 2017. I have a strong clinical interest in HPV associated cervical disease and therapeutic vaccination against HPV. I am leading a research programme in the field of the molecular basis and clinical managment of cervical dysplasia.
In addition, I am a board member of the British Society for Colposcopy and Cervical Pathology (BSCCP) and an accredited colposcopy trainer. I am an elected member of the Society for Reproductive Investigation (SRI). In my spare time I volunteer as expert reviewer for Jo's Cervical Cancer Trust Charity.
Areas of interest
Colposcopy (examination of vagina and cervix); HPV; Cervical screening; Abnormal smear; HPV vaccination; Gynaecological assessment; Gynaecological ultrasound scanning
Current NHS consultant posts held
Lead Consultant for Colposcopy
Oxford University Hospitals NHS Foundation Trust
John Radcliffe Hospital
Women’s Center, Level 3
HPV associated carcinogenesis and therapeutic HPV vaccines
(Additional) Languages spoken
- German - Native or bilingual
Hellner K, Dorell L: Recent advances in understandig and preventing HPV disease; F1000 Reviews 2017
Hancock G, Hellner K, Dorrell L: Therapeutic HPV Vaccines, Best Pract Res Clin Obstet Gynaecol. 2018
Hellner K, Münger K: Human papillomaviruses as therapeutic targets in human cancer; J. Clin Oncol 2011
Reference number 7094959
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.